 |
 |
The Motley Fool... Biotechnology company Geron (Nasdaq: GERN) has been given a patent for claims associated with human embryonic germ cells. The company hopes to parlay its understanding of these and other cells into treatment for such diseases as Parkinson's disease, diabetes, spinal cord injuries, liver disease, and heart disease. http://www2.uclick.com/client/isn/fd/ ********** ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn